NASDAQ:CYRN - Cyren Stock Price, Forecast & News

Cyren trades on the NASDAQ under the ticker symbol "CYRN."

Cyren Ltd (NASDAQ:CYRN) issued its quarterly earnings data on Wednesday, November, 13th. The technology company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. The technology company earned $9.50 million during the quarter, compared to the consensus estimate of $9.80 million. Cyren had a negative net margin of 47.56% and a negative return on equity of 68.95%. View Cyren's Earnings History.

Cyren is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Cyren.

1 analysts have issued 1-year price objectives for Cyren's stock. Their forecasts range from $3.00 to $3.00. On average, they anticipate Cyren's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 134.4% from the stock's current price. View Analyst Price Targets for Cyren.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cyren in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cyren.

News headlines about CYRN stock have trended extremely negative this week, InfoTrie reports. The research firm ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cyren earned a media sentiment score of -4.5 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Cyren.

Cyren saw a decline in short interest during the month of January. As of January 15th, there was short interest totalling 15,200 shares, a decline of 35.3% from the December 31st total of 23,500 shares. Based on an average trading volume of 30,600 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.1% of the company's shares are sold short. View Cyren's Current Options Chain.

Some companies that are related to Cyren include ChannelAdvisor (ECOM), DIRTT Environmental (DRTT), Red Violet (RDVT), eGain (EGAN), Iclick Interactive Asia Group (ICLK), Smith Micro Software (SMSI), MAM Software Group (MAMS), Inspired Entertainment (INSE), SharpSpring (SHSP), Great Elm Capital Group (GEC), Aware (AWRE), Medical Transcription Billing (MTBC), Where Food Comes From (WFCF), Mobivity (MFON) and ImageWare Systems (IWSY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), NovaBay Pharmaceuticals (NBY), Athersys (ATHX), Biocept (BIOC), AVEO Pharmaceuticals (AVEO), Corbus Pharmaceuticals (CRBP), Inpixon (INPX), MEI Pharma (MEIP), Onconova Therapeutics (ONTX) and Pacific Ethanol (PEIX).

Shares of CYRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CYRN stock can currently be purchased for approximately $1.28.

Cyren has a market capitalization of $75.93 million and generates $35.90 million in revenue each year. The technology company earns $-19,410,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. Cyren employs 248 workers across the globe.View Additional Information About Cyren.

The official website for Cyren is http://www.cyren.com/.

Cyren's mailing address is 10 Ha-Menofim St. 5th Floor, Herzliya L3, 4672561. The technology company can be reached via phone at 972-9863-6888 or via email at [email protected]